baber/WOPTO huggingface dataset:
Patent PT-808856-E (PT)
Inventor: NOCCI ROBERTO
IPC: C08F287/00
Filed: 1997-04-30
Abstract: Process for the preparation of ABS which comprises:   a) preparing a solution consisting of a diblock linear rubber of the type S-B dissolved in a mixture of monomers comprising styrene and acrylonitrile; b) feeding to the solution of step (a) at least one preformed ABS resin having an average volumetric diameter of the rubber particles contained in the polymeric matrix of more than 1.5  mu ;   c) dissolving the preformed ABS in the solution of step (a); d) feeding in continuous the solution thus obtained to a polymerization reactor for ABS resins; e) polymerizing the final solution to produce an ABS with a multimodal morphology.
Patent PT-888174-E (PT)
Inventor: RUOTTU SEPPO
IPC: B01J8/00
Filed: 1997-09-01
Abstract: The invention relates ro a method of converting hydrocarbons. According to the method, a gaseous or liquid hydrocarbon feed is passed into a circulating fluidized-bed reactor, wherein the feed is converted at a high temperatue under the influence of particulate matter kept in a fluidized state, and the converted hydrocarbon products are removed from the reactor in a gaseous phase. According to the invention, a circulating fluidized-bed reactor (1-3; 41-43) is used having an axially annular cross section and being equipped with a multiport cyclone (14,17; 52,63) for the separation of the particulate matter from the gas-phase reaction products. The reaction space comprises an intershell riser space (13; 50) formed between two concentrically located cylindrical and/or conical envelope surfaces. The separation of particulate matter from the gas-phase reaction products is performed by means of a multiport cyclone equipped with louvered vanes (14; 63).
Patent PT-923576-E (PT)
Inventor: NEWSHAW RICHARD ERIC
IPC: A61K31/40
Filed: 1997-08-26
Abstract: A compound of formula (I) in which Y is hydrogen, halogen or alkoxy; R is hydrogen or alkylthio; R1 is hydrogen or alkyl; X is hydrogen, halogen, alkoxy, alkyl or phenyl; n is one of the integers 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof are inhibitors of dopamine synthesis and release, useful in the treatment of shizophrenia, Parkinson's Disease, Tourette's Syndrome, alcohol addiction, cocaine addiction, and addiction to analogous drugs.
Patent PT-876762-E (PT)
Inventor: BIEZE TAMMO WILLEM NICOLAAS
IPC: C02F1/72
Filed: 1998-05-05
Abstract: Composition having disinfecting action comprising:     (a) 35-75 wt.% of hydrogen peroxide   (b) 10-150 ppm of silver   (c) 1-100 ppm of inorganic acid   (d) 0-100 ppm of organic stabilizer, and   (e) 25-65 wt.% of water,  wherein the inorganic acid:silver molar ratio is less than 1. The composition can be prepared by mixing the inorganic acid with water, adding a silver compound to this solution, then adding, if desired, an organic stabilizer, and finally adding a solution of hydrogen peroxide in water (for example 35-50 wt.% of H2O2) to the mixture thus obtained. The composition is very suitable as disinfectant for water in swimming pools.
Patent PT-976867-E (PT)
Title: Process for finishing a textile and finishing baths
Inventor: WILHELM DIDIER
IPC: D06M101/06
Filed: 1999-07-22
Abstract: Process for finishing a cellulose-based textile according to which the textile is treated using an aqueous finishing bath containing the following cross-linking composition as a cross-linking agent for cellulose:   a) 15 - 95 molar % of at least one maleic acid and hypophosphorus acid telomer of formula (I) <CHEM>  with <CHEM>       and (m+n) ≥ 3   or A = H or OH and n ≥ 2     b) 0 - 50 molar % phosphinicosuccinic acid   c) 0 - 40 molar % of phosphinicobissuccinic acid   d) 0 - 50 molar % phosphonosuccinic acid   e) 0 - 15 molar % hypophosphorus acid   f) 0 - 10 molar % phosphorus acid   g) 0 - 15 molar % phosphoric acid each of the acids a) to g) of the composition being able to be present either in free form or partially or totally neutralized in the form of an alkali metal or alkaline-earth metal ammonium or amine salt and finishing bath.
Patent PT-1053367-E (PT)
Inventor: SAINT-VICTOR MARIE-ESTHER
IPC: D21C3/22
Filed: 1999-01-28
Abstract: Enhanced removal of lignin and other extractives in a pulping process is achieved by contacting wood chips and the like with a liquid mixture comprised of white liquor and aminoalkoxylsilane and optionally, one or more nonionic and/or anionic surfactants.
Patent PT-1082385-E (PT)
Inventor: WILHELM THOMAS
IPC: C08J9/32
Filed: 1999-02-20
Abstract: In order to provide a moulding composition which makes it possible to form shaped components having not only one but two or more visible sides, it is proposed that this composition comprise a methyl-methacrylate-based syrup and up to 85%, expressed in terms of the moulding composition, of an inorganic filler, and that the moulding composition comprise deformable, propellant-filled hollow microspheres having a plastic wall which is essentially insoluble in methyl methacrylate, the proportion by volume of the hollow microspheres to the total volume of the moulding composition being in the 5 to 50 vol. % range.
Patent PT-1140465-E (PT)
Inventor: NUMRICH UWE
IPC: B29C48/86
Filed: 1999-12-03
Abstract: A film comprising at least one layer of fluorine polymers and poly(meth)acrylates is prepared by (i) preparing a mixture of fluorine polymer and poly(meth)acrylate; and (ii) extruding the mixture maintained below its gel-forming temperature through the die of an extruder having a filter placed before entry of the mixture into the die, the temperature of the die being maintained higher than the temperature of the composition upon entry into the die but lower than the gel-forming temperature of the mixture, onto a roll having a temperature <=100° C., thereby forming the at least one layer in the shape of a film.
Patent IE-790193-L (IE)
Title: Resinous polymer sheet material
IPC: B41M1/30
Filed: 1979-02-01
Abstract: Resinous polymer sheet material having surface decorative effects. The material is made by applying to a potentially foamable resinous composition (16) a printing composition layer (18) forming a pattern and then applying to said printing composition layer a resinous polymer wear layer (22) having therein reactive polymerizable and cross-linkable monomeric materials. There is included in areas (20) of the sheet material a polymerization initiator, perferably dicumylperoxide, capable of initiating a polymerization and cross-linking reaction of the monomeric materials, and the surface of the wear layer is heated in order to develop the foam, preferably also mechanically embossed, and to bring about such reaction at the areas of the polymerization initiator. The melt viscosity of the wear layer at said areas is thereby increased so that said areas will have a different appearance than the other area of said wear layer.
[EP0003965A1]
Patent IE-800236-L (IE)
Title: Esters.
IPC: A61K31/22
Filed: 1980-02-07
Abstract: Novel compounds of the formula <IMAGE> wherein R is 3-pyridinyl or 2-(4- chlorophenoxy)-2-methyl-propyl; R<1> is hydrogen, C5-14 cycloalkyl, (C5-14 cycloalkyl)methyl, (C5-14 cycloalkyl)carbonyl, (C5-14 cycloalkyl)acetyl, 1-adamantyl, 1- adamantylmethyl, 1-adamantylcarbonyl, 1-adamantylacetyl, cumyl, p-chlorobenzoyl, piperidino or 2- pyrimidinyl; and R<2> is hydrogen, -(CH2)4-, halogen, C1-6 alkyl, cycloalkyl, methoxy, ethoxy, trifluoromethyl or nitro; provided that R<2> is C1-6 cycloalkyl or -(CH2)4- when R<1> is hydrogen; or a pharmaceutically acceptable acid addition salts thereof may be used in the treatment of hyperlipidemias.
[GB2041937A]
Patent IE-890242-L (IE)
Title: Pouched granular detergent
IPC: C11D3/60
Filed: 1989-01-26
Abstract: A porous, pouched granular detergent compositions containing an organic surfactant, preferably an aluminosilicate ion exchange material, and water-soluble neutral or alkaline hygroscopic detergency builder salt, preferably an ether polycarboxylate. The pouched compositions contain no or low levels of phosphate and silicate materials, yet provide granules which exhibit at least initial free-flowing granular characteristics, reduced dusting and unexpectedly good/equivalent solubility in the laundering solution notwithstanding the development of lumps upon storage under stress conditions.
[EP0326208A2]
Patent IE-33760-L (IE)
Title: Morpholine derivatives
IPC: C07D295/08
Filed: 1970-03-23
Abstract: 1,253,947. Morpholines. CARLO ERBA S.p.A. 10 April, 1970 [15 April, 1969], No. 17286/70. Heading C2C. Novel morpholines of the general formula wherein R is a hydrogen or halogen atom or a trifluoromethyl, C 1-4 alkyl, C 1-4 alkoxy or optionally substituted amino group, A is a carbonyl group or a group of formula -CR<SP>1</SP>R<SP>2</SP>-, in which R<SP>1</SP> is a hydrogen atom or a C 1-4 alkyl, hydroxymethyl or hydroxy group and R<SP>2</SP> is a hydrogen atom or a C 1-4 alkyl group, n is an integer from 1 to 3, R<SP>3</SP> is a hydrogen or halogen atom or a C 1-4 alkyl or C 1-4 alkoxy group and R<SP>4</SP> and R<SP>5</SP> are each a hydrogen atom or a C 1-4 alkyl group, and pharmaceutically acceptable acid addition salts thereof are prepared (a) by reaction of a phenolate and a halide of the respective general formulµ wherein M is an alkali metal atom and Y is a halogen atom; (b) by reaction of a halide and a morpholine of the respective general formulµ (c) when A is a group of formula -CR<SP>1</SP>R<SP>2</SP>-, in which R<SP>1</SP> is a hydroxy group and R<SP>2</SP> is a hydrogen atom, or R<SP>1</SP> and R<SP>2</SP> are each a hydrogen atom, by reduction of the corresponding morpholine of the first general formula above wherein A is a carbonyl group; (d) when R is an amino group, by reduction of the corresponding morpholine of the first general formula above wherein R is a nitro group and optional conversion of the resulting compound wherein R is an unsubstituted amino group to the corresponding compound wherein R is a substituted amino group by methods known per se; (e) when A is a carbonyl group, by reaction of a nitrile and a Grignard reagent of the respective general formulµ wherein X is a halogen atom, followed by hydrolysis; (f) when A is -CHOH-, by reaction of an aldehyde of the general formula with a Grignard reagent of the seventh general formula above, followed by hydrolysis; and (g) when A is a carbonyl group, by oxidation of the corresponding morpholine of the first general formula above wherein A is a group of formula -CR<SP>1</SP>R<SP>2</SP>-, in which R<SP>1</SP> is a hydroxy group and R<SP>2</SP> is a hydrogen atom; followed optionally by salification of the product with the appropriate acid. Halides of the fourth general formula above are prepared by reaction of a phenolate of the second general formula above with a dihalide of the general formula Pharmaceutical compositions having antitussive activity comprise, as active ingredient; a morpholine of the first general formula above or a pharmaceutically acceptable acid addition salt thereof, together with a pharmaceutically acceptable carrier or diluent, and may be administered orally.
[GB1253947A]
Patent IE-880424-L (IE)
Title: Preparing azetidinones.
IPC: C07F7/18
Filed: 1988-02-16
Abstract: A process for preparing a 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having the formula (II): <CHEM> wherein R<1> is a protective group for the hydroxyl group, which comprises reacting a beta -lactam compound having the formula (I): <CHEM> wherein R<1> is as difined above and R<2>, R<3> and R<4> are the same or different and each is a lower alkyl group having 1 to 4 carbon atoms or an aralkyl group, with acetic anhydride in the presence of a base and a catalyst selected from the group consisting of an organic strong acid, a mineral acid, a Lewis acid, a halogenated acyl compound having the formula (IV): R<8>-CO-X (IV) wherein R<8> is an alkyl group, an aralkyl group or phenyl group and X is a halogen atom, a halogenated sulfonyl compound having the formula (V): R<9>-SO2-X (V) wherein R<9> is an alkyl group, an aralkyl group or phenyl group and X is a halogen atom, and a compound having the formula (VI): (R<1><0>)4-n-Si(X')n (VI) wherein R<1><0> is a lower alkyl group having 1 to 6 carbon atoms or phenyl group, X' is a halogen atom or CF3SO2O group and n is an integer of 1 to 4. According to the present invention, there can be obtained 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives, which are useful intermediates for preparing carbapenem beta -lactam antibiotics, in high yield.
[EP0280962A1]
Patent IE-800471-L (IE)
Title: Ascorbic acid decomposition
IPC: C12Q1/54
Filed: 1980-03-07
Abstract: The present invention provides a process for removing ascorbic acid from aqueous solutions by the addition of ascorbate oxidase, wherein catalase and hydrogen peroxide are also added to the solution. The present invention also provides an agent for the removal of ascorbic acid from aqueous solutions, based on a solid carrier material impregnated with ascorbate oxidase, wherein the carrier material also contains catalase and hydrogen peroxide and optionally also a stabilizer and/or buffer substance.
[US4563422A]
Patent IE-40833-L (IE)
Title: Reinforced absorbent web
IPC: A61F13/53
Filed: 1975-03-18
Abstract: 1494525 Folding edges; laminates PROCTER & GAMBLE CO 18 March 1975 [18 March 1974] 11246/76 Headings B5K and B5N [Also in Divisions D1-D2 and A3] A reinforced absorbent web 13 for a diaper is formed by treating at least one surface of an uncompacted absorbent web 1 of hydrophilic fibres having a basis weight of 80 to 500 g/m<SP>2</SP> and a density of 0À03 to 0À05 g/cc. by applying a hydrophobia, film-forming material thereto to give a total treated depth not exceeding 50% of the total thickness of the uncompacted web, drying the film-forming material and compacting the web to an overall density of 0À07 to 0À15 gms/cc., the density of the treated surface(s) being lower than that of the untreated portions, thereby providing a graduation of capillary size favourable for the transmission of liquid from the treated to the untreated portions. Unspecified hydrophilic cellulosic fibres are air laid at 2 and the continuous web sprayed at 3 with a 10 to 55% aqueous dispersion of a styrene-butadiene or acrylic resin having a glass transition temperature of -15 C. to + 35 C. to give a 5 to 16 g/cm<SP>2</SP> uptake of solids. Selected areas may have different or zero amounts of resin applied. The moisture content is reduced to less than 5% and the resin cured by air at at least 270 F. supplied by dryer 5. The web is then calendered by rolls 9, 10, the resin preventing inter-fibre hydrogen bonding in the treated portion 13b whilst the untreated portion 13a is densified. Diapers, laminating, seaming.-The endless web 1 is cut into pads 13 by knife 11 and the pads separated. An impervious matt finish polyethylene backing 15 is sprayed with a soft pressure-sensitive polyvinyl acetate copolymer adhesive 17 and laminated to the spaced assembly of pads 13. A low density hydrophobic top sheet 16 comprising a needle bunched polyester fabric or a viscose rayon fabric printed with discrete areas of hydrophobic binder is pressed against the resin treated portion 13b of each pad. Beads 19 of hot melt adhesive are applied to each edge of sheet 16. Ploughs 21 turn over each edge of sheets 15, 16. Hardsurfaced rolls 22, 24 press each turned over edge together and press the adhesive coated sheet 15 to the top sheet 16 in the areas between the pads 13, roll 22 having recessed areas 23 to accomodate pads 13. The turning over of the edges prevents rucking by top sheet 16. Alternatively this can be achieved without turning over by sizing the edges of sheet 16. Pressure sensitive tape for securing the diaper is applied to each pad, the pads folded to the configuration of Fig. 6 and the pads separated by cutting the sheets 15, 16.
[GB1494525A]
Patent IE-820594-L (IE)
Title: Carnitine esters
IPC: A61K/
Filed: 1982-03-15
Abstract: A novel class of esters of mercapto acyl-carnitines is disclosed, wherein the mercapto acyl radical is the radical of saturated mercapto acids having from 2 to 10 carbon atoms. These esters of mercapto acyl-carnitines are prepared e.g. by first preparing the corresponding ester of halogen acyl-carnitine and then substituting therein, by nucleophylic substitution, the -SH group for the halogen atom. These esters of mercapto acyl-carnitines are useful therapeutic agents, e.g. for the treatment of intoxications and burns, and as mucolytic agents.
[US4567200A]
Patent IE-830746-L (IE)
Title: Boosting circuit
IPC: H03K5/02
Filed: 1983-03-31
Abstract: PURPOSE:To simplify the 2nd buffer circuit in a multichannel input circuit smoothly, by forming each of capacitors with a depletion MOS capacitor. CONSTITUTION:Each of boosting circuits 41 is provided with depletion MOS capacitors 42-1-42-n, and the 2nd buffer circuit of each channel is used in common with the single 2nd buffer circuit 22'. A timing pulse -phi' is applied to the new 2nd buffer circuit 22' in place of an address signal. In this case, a capacitor selected from the MOS capacitors 42-1-42-n only has an increased capacitance value and the remaining MOS capacitors have a small capacitance value. Thus, the capacitor component always corresponds to the selected one MOS capacitor from the single 2nd buffer circuit 22', thereby preventing the capacitor load from being increased.
[JP58184821A]
Patent IE-790913-L (IE)
Title: Stranding machine
IPC: D07B3/00
Filed: 1979-08-08
Abstract: An apparatus for cabling wires into a predetermined stranded configuration has at least one first pay-off bobbin rotatably supported inside a carrier, in its turn freely rotating inside a cage-type device and coaxial with it. The cage is supported to rotate about its own axis. Part of the wires constituting the produced cord can be drawn through the apparatus coming from a second, external to the apparatus, pay-off bobbin. The carrier comprises means for guiding the wires along a path developed from one extremity and/or from the first pay-off bobbins to the other extremity of said carrier, said path being not coincident with the axis of the apparatus, and means, disposed along said path, for permanently deforming the wires by bending.
[US4335571A]
Patent IE-880956-L (IE)
Title: A software verification apparatus
IPC: G06F11/36
Filed: 1988-03-30
Abstract: An apparatus for verification of target software loaded in a target computer. The apparatus includes communication and monitoring circuits inserted in the target computer and in a host computer which is programmed to direct operation of target software tests through the communication and monitoring circuits. The communication and monitoring circuits transmit external stimuli to the target software in a non-intrusive manner by, for example, keyboard simulation. The communication and monitoring circuits also capture target software output data for comparison with reference data stored in the host computer. Both of these operations are carried out in a non-intrusive manner in hardware, (the communication and monitoring circuits). The external stimuli including test instructions may be either recorded in a manual recording session or may be generated in the host computer. Similarly, the target software output reference data may be either generated in the host computer or recorded in a manual session. The apparatus is particularly suitable for regression testing and enables a user to detect faults at any stage of software development irrespective of how many updates are involved.
[US5022028A]
Patent FI-851859-L (FI)
Inventor: NOVOTNY PAVEL
IPC: A61K39/10
Filed: 1985-05-10
Abstract: The present invention provides novel antigenic preparations comprising proteinaceous material associated with adenylate cyclase activity in cultures of B.pertussis, the said preparations being useful as components of acellular whooping cough vaccines. The invention further provides methods for the isolation of such antigenic preparations.
Patent FI-852190-L (FI)
Inventor: FEELY WAYNE EDMUND
IPC: G03F7/022
Filed: 1985-05-31
Abstract: This invention is concerned with the formation of thermally stable positive and negative images on substrate surfaces, the images being capable of withstanding heating to at least 200 DEG C without significant loss in image quality or resolution. The images are formed from a dual acting, aqueous developable, crosslinkable polymer coating which is itself formed from a thermally stable, photosensitive coating composition comprising acid hardening resin system and photoacid generator dissolved in solvent. The coating compositions may also be used to form protective coatings and planarizing layers on substrate surfaces.
Patent IE-42422-L (IE)
Title: Triazoloisoindole derivatives
IPC: C07D217/00
Filed: 1974-05-24
Abstract: 1477302 Triazolo-isoindole and -isoquinoline derivatives GRUPPO LEPETIT SpA 28 May 1974 [25 May 1973 22 Aug 1973] 25163/73 and 21585/74 Heading C2C Novel compounds I (A is -CH 2 -, -CH 2 CH 2 - or -CH : CH-; R 1 and R 2 are H, Cl, or 1-5C alkoxy; and R is H NH 2 , 1-5C alkylamino, di-(1-5C alkyl)- amino, acylamino, diacylamino, ureido, thioureido, carbethoxythioureido, benzoylthioureido, sulphydryl, 1-5C alkyl, CF 3 , phenyl, substituted phenyl, pyridyl, methylpyridyl or dimethylpyridyl; with the provisos that (i) when A is -CH 2 CH 2 - or -CH : CH-, R cannot be H, alkyl, CF 3 or phenyl; and (ii) when A is -CH : CHR also cannot be tolyl or pyridyl) and compounds I not subject to the provisos are prepared by reacting a compound II with a compound RZ (Z = CN, CONH 2 , -CSNH 2 , or -C(NH)S alkyl to yield a compound III and cyclizing this compound by refluxing in a solvent in the presence of a strong base and, if a compound I where A is -CH : CH- is required, dehydrogenating a corresponding compound I where A is -CH 2 CH 2 -. Compounds I where A is -CH 2 - may also be prepared by cyclizing a compound IV in the presence of a strong base. Pharmaceutical compositions comprise a compound I together with a suitable diluent or carrier and are useful as anti-inflammatory agents, CNS depressants, antifertility agents for oral or parenteral administration.
[GB1477302A]
Patent IE-37698-L (IE)
Title: Collagen compositions.
IPC: A22C13/00
Filed: 1972-08-31
Abstract: 1408301 Sausage casings UNION CARBIDE CORP 31 Aug 1972 [1 Sept 1971] 40367/72 Heading A2B [Also in Division C3] Edible, shaped collagen structures, e.g. sausage casings are obtained by (a) preparing a viscous, aqueous dispersion of non-collagenous fibres, said aqueous dispersion containing a viscosity control agent; (b) preparing a comminuted pre-swollen collagen mass; (c) thoroughly mixing said aqueous fiber dispersion with said pre-swollen collagen mass until a uniform admixture is obtained while maintaining the temperature of said admixture below about 35C; and (d) feeding said uniform collagen-non-collagenous fiber admixture to and through the extrusion zone of an extruder to produce the shaped collagen structure. The non-collagenous fibres may be cellulosic e.g. wood, cotton or rayon or they may be polyester, polyamide, polyimide, polyolefin, alginate or starch. The viscosity control agents used include carboxymethyl cellulose, gelatin, starch, glycerin or a dispersion of swollen collagen particles.
[GB1408301A]